Inari Medical, Inc. provided earnings guidance for the full year 2024. For the period, the company expects revenue of $592.5 million to $602.5 million, reflecting growth of approximately 20% to 22% over 2023, and a raise versus the prior 2024 revenue guidance of $580 million to $595 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.9 USD | -1.58% | -5.26% | -26.61% |
May. 23 | Sector Update: Health Care Stocks Lower Thursday Afternoon | MT |
May. 23 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.61% | 2.83B | |
+75.69% | 12.57B | |
+6.07% | 6.66B | |
+15.10% | 5.5B | |
-17.86% | 4.88B | |
+14.96% | 4.1B | |
-20.83% | 3.89B | |
+45.95% | 2.31B | |
+2.23% | 2.07B | |
+9.75% | 1.97B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Provides Earnings Guidance for the Full Year 2024